Herein we report the development of a methodology for the dual-functionalisation of IgG antibodies. This is accomplished through the combination of disulfide rebridging divinylpyrimidine technology, with bicyclononyne and methylcyclopropene handles to facilitate sequential SPAAC and IEDDA reactions. Advantageously, the strategy does not require metal catalysis and avoids the need for purification between functionalisation steps.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387566 | PMC |
| http://dx.doi.org/10.1039/d2cc02515a | DOI Listing |
Publication Analysis
Top Keywords
disulfide rebridging
8
antibody dual-functionalisation
4
dual-functionalisation enabled
4
enabled modular
4
modular divinylpyrimidine
4
divinylpyrimidine disulfide
4
rebridging strategy
4
strategy report
4
report development
4
development methodology
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!